Last updated on September 2018

A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)


Brief description of study

The purpose of the current study is to evaluate the efficacy and safety of TEV-48125 (Fremanezumab), in the prevention of CCH in adult patients.

Clinical Study Identifier: NCT02964338

Contact Investigators or Research Sites near you

Start Over

Teva U.S. Medical Information

Teva Investigational Site 80127
Tel Aviv, Israel

Teva U.S. Medical Information

Teva Investigational Site 80126
Tel-Aviv, Israel

Teva U.S. Medical Information

Teva Investigational Site 80120
Ramat Gan, Israel
2.78miles

Teva U.S. Medical Information

Teva Investigational Site 80121
Jerusalem, Israel
4.56miles

Teva U.S. Medical Information

Teva Investigational Site 80125
Holon, Israel
4.81miles